Investors in Health Care

Enterprise Equity is a venture capital firm with over 25 years of experience investing in internationally focused Irish companies. They provide funding for early-stage, high-growth technology businesses, offering more than just capital by delivering sound corporate governance and strategic advice. As the Investment General Partner of the AIB Seed Capital Fund with a committed fund size of €53 million, they support start-ups and early-stage companies in Ireland with significant growth potential.

Seroba is a leading European life sciences venture capital firm, dedicated to creating value by supporting innovative biotech and medtech companies. With a focus on breakthrough technologies, Seroba has backed significant advancements such as Shorla Oncology's FDA-approved TEPYLUTE, a ready-to-dilute formulation for treating breast and ovarian cancer. Based in Dublin, Seroba leverages deep industry expertise to help entrepreneurs build world-class businesses, fostering extraordinary scientific innovations.

Neo Ventures is a deep tech fund that invests in the builders of digital infrastructure for smart cities, outpatient healthcare, and space missions. For nearly a decade, they have supported artificial intelligence and machine learning technology startups in developing and deploying reliable, scalable data solutions that serve billions today. Neo Ventures provides comprehensive support to founders, including business planning, scaling operations, follow-on investments, maximizing opportunities, and navigating challenging situations.

DHP Capital is an investment firm that invests in digital healthcare venture cases. We are deeply rooted in the healthcare industry with a strong international network. DHP Capital is a stage-agnostic investor with an exclusive focus on Healthcare Technology companies. We invest in businesses with best-in-class technologies and aim to scale them into digital leaders.

Hitachi Ventures is the global venture capital arm of Hitachi Group, a global industrial player active in a broad range of technology sectors. Hitachi Ventures invests in innovative companies that address society’s key technological, social and environmental challenges in areas like IT, industrial automation (robotics, sensor technology and IoT). Hitachi intends to leverage its strong position in multiple global technology markets, its expertise and network to support and promote Hitachi Ventures portfolio companies.

The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche. Roche has allocated CHF 500 million to invest in and develop commercially successful innovative life science companies. Roche has been investing in early-stage companies as part of collaborations since the early-1990s and independent of collaborations since 2002. All equity investments made by Roche in biotech and diagnostics companies (including collaboration investments) are negotiated and managed by the Roche Venture Fund.

SevenVentures is a leading TV media investor. As the investment arm of the ProSiebenSat.1 Group, they are the ideal partner for B2C growth companies, especially in the consumer goods, retail and service sectors that have the potential to achieve sustainable success through the use of TV advertising. The combination of media power and operational know-how make SevenVentures the premier partner for growth through target-group-related and far-reaching TV and digital campaigns.

We empower early stage tech startups with software development, IT advisory and growth support. For a better tomorrow.Twip Impact Ventures is a strategic partner for impact startups, providing IT investments, software development, and growth support. They empower early-stage tech startups to accelerate their growth and impact

The NHS Innovation Accelerator (NIA) is an NHS England Initiative delivered in partnership with the Country’s 15 Academic Health Science Networks (AHSNs), hosted by UCLPartners. It supports delivery of the Five Year Forward View by accelerating the uptake of high impact innovations for the patient, population and NHS staff benefit, and providing real-time practical insights on spread to inform national strategy. Fellows supported by the NIA all share a set of values and passion for scaling evidence-based innovation to benefit a wider population, with a commitment to share their learnings. Some impressive results have been achieved by Fellows since the NIA launched in July 2015: 1,423 additional NHS sites now using NIA innovations; £45.2m in external funds secured; 52 awards won; 226 jobs created; and 21 innovations selling internationally. In addition, impact data is already available at adopter sites and this demonstrates earlier intervention, reductions in complications and emergency admissions, alongside cost savings.

Cognitive Corporate Finance is a cutting-edge, technology-enhanced, Big Data-powered third millennium merchant advisory firm Through an intimate knowledge of investors’ needs, as well as through unparalleled contacts, we bring our clients the most relevant advice, the optimal financial solution and the best and fastest service in finding capital or strategic partners for their corporate requirements

Founded in August 2015, Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals. Our primary focus is to identify and invest in emerging companies in the digital health space, globally, that could enhance Hikma’s value proposition, reputation and market intelligence. We will also consider investments in other healthcare related areas of current or future strategic interest to Hikma, including drug delivery technologies that have the potential to enhance Hikma's value chain and pipeline.

A subsidiary of Swiss health insurance Helsana, our goal is to improve efficiency and the provision of care in the Swiss healthcare system. Helsana Health Invest invests in start-ups dedicated to health. It’s our way of contributing to a higher quality of healthcare and increasing efficiency in the healthcare system. Helsana: Switzerland's top health insurer offering comprehensive health and accident insurance services to individuals and companies, with over 1.9 million policyholders and a strong focus on prevention and occupational health management.